Ajanta Pharma Ltd

BOM:532331 (India)   Ordinary Shares
₹ 2393.90 (-1.04%) May 29
36.73
P/B:
8.40
Market Cap:
₹ 301.43B ($ 3.61B)
Enterprise V:
₹ 296.99B ($ 3.56B)
Volume:
8.31K
Avg Vol (2M):
6.95K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Ajanta Pharma Ltd ( BOM:532331 ) from 2000 to May 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Ajanta Pharma stock (BOM:532331) PE ratio as of May 31 2024 is 36.73. More Details

Ajanta Pharma Ltd (BOM:532331) PE Ratio (TTM) Chart

To

Ajanta Pharma Ltd (BOM:532331) PE Ratio (TTM) Historical Data

Total 1265
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Ajanta Pharma PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-31 37.0 2024-03-20 35.7
2024-05-29 37.0 2024-03-19 36.1
2024-05-28 37.3 2024-03-18 36.5
2024-05-27 37.6 2024-03-14 36.5
2024-05-24 37.4 2024-03-13 36.6
2024-05-23 37.0 2024-03-12 35.8
2024-05-22 36.7 2024-03-11 36.1
2024-05-21 37.0 2024-03-07 35.8
2024-05-17 36.7 2024-03-06 35.8
2024-05-16 37.0 2024-03-05 35.9
2024-05-15 37.0 2024-03-04 35.5
2024-05-14 37.6 2024-03-01 36.5
2024-05-13 36.8 2024-02-29 37.9
2024-05-10 36.7 2024-02-28 35.7
2024-05-09 37.2 2024-02-27 36.5
2024-05-08 36.5 2024-02-26 36.6
2024-05-07 37.0 2024-02-23 36.5
2024-05-06 37.3 2024-02-22 36.4
2024-05-03 36.7 2024-02-21 36.4
2024-05-02 34.5 2024-02-20 36.3
2024-04-30 34.2 2024-02-19 36.8
2024-04-29 34.1 2024-02-16 37.0
2024-04-26 34.0 2024-02-15 37.0
2024-04-25 33.0 2024-02-14 36.4
2024-04-24 32.9 2024-02-13 37.1
2024-04-23 33.0 2024-02-12 37.3
2024-04-22 32.3 2024-02-09 37.1
2024-04-19 32.1 2024-02-08 37.9
2024-04-18 32.1 2024-02-07 38.8
2024-04-16 31.9 2024-02-06 39.0
2024-04-15 32.5 2024-02-05 37.1
2024-04-12 32.7 2024-02-02 37.2
2024-04-10 33.1 2024-02-01 37.5
2024-04-09 33.2 2024-01-31 37.3
2024-04-08 33.0 2024-01-30 36.3
2024-04-05 33.6 2024-01-29 37.4
2024-04-04 33.5 2024-01-25 37.6
2024-04-03 34.9 2024-01-24 37.7
2024-04-02 35.0 2024-01-23 37.8
2024-04-01 34.5 2024-01-19 37.7
2024-03-28 34.5 2024-01-18 38.0
2024-03-27 37.5 2024-01-17 38.7
2024-03-26 38.1 2024-01-16 39.5
2024-03-22 36.9 2024-01-15 38.6
2024-03-21 36.4 2024-01-12 37.4

Ajanta Pharma Ltd (BOM:532331) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.